+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Alpha Glucosidase Inhibitors Market 2024-2028 - Product Thumbnail Image

Alpha Glucosidase Inhibitors Market 2024-2028

  • Report
  • August 2024
  • 135 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (elisa) Market 2024-2028 - Product Thumbnail Image

Enzyme-linked Immunosorbent Assay (elisa) Market 2024-2028

  • Report
  • August 2024
  • 192 Pages
  • Global
From
Hypodermic Needles Market 2025-2029 - Product Thumbnail Image

Hypodermic Needles Market 2025-2029

  • Report
  • July 2025
  • 213 Pages
  • Global
From
Hemophilia Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Hemophilia Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 193 Pages
  • Global
From
RNAi Drug Delivery: Technologies and Global Markets - Product Thumbnail Image

RNAi Drug Delivery: Technologies and Global Markets

  • Report
  • August 2023
  • 141 Pages
  • Global
From
Insulin Sensitizers - Global Strategic Business Report - Product Thumbnail Image

Insulin Sensitizers - Global Strategic Business Report

  • Report
  • November 2025
  • 340 Pages
  • Global
From
Insulin-like Growth Factors - Global Strategic Business Report - Product Thumbnail Image

Insulin-like Growth Factors - Global Strategic Business Report

  • Report
  • November 2025
  • 270 Pages
  • Global
From
Growth Hormone Deficiency - Global Strategic Business Report - Product Thumbnail Image

Growth Hormone Deficiency - Global Strategic Business Report

  • Report
  • November 2025
  • 475 Pages
  • Global
From
From
Prediabetes - Global Strategic Business Report - Product Thumbnail Image

Prediabetes - Global Strategic Business Report

  • Report
  • November 2025
  • 287 Pages
  • Global
From
From
Human Insulin - Global Strategic Business Report - Product Thumbnail Image

Human Insulin - Global Strategic Business Report

  • Report
  • November 2025
  • 376 Pages
  • Global
From
Metabolic Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Metabolic Disorder Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 286 Pages
  • Global
From
Addison's Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Addison's Disease Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 278 Pages
  • Global
From
Diabetic Ketoacidosis - Global Strategic Business Report - Product Thumbnail Image

Diabetic Ketoacidosis - Global Strategic Business Report

  • Report
  • November 2025
  • 279 Pages
  • Global
From
Endocrinology Drugs - Global Strategic Business Report - Product Thumbnail Image

Endocrinology Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 288 Pages
  • Global
From
Hormone Replacement Therapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Hormone Replacement Therapy Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
Loading Indicator